Greetings from the Director
  • Phase I dose escalation study using proton beam therapy for chordomas, chondrosarcomas, and atypical or malignant meningiomas [active]
    Institutional principal investigator: Kwan Ho Cho
  • Phase I dose escalation study using proton beam therapy for recurrent chordomas, chondrosarcomas, and atypical or malignant meningiomas after Previous Radiotherapy [active]
    Institutional principal investigator: Kwan Ho Cho
  • A randomized phase II study for the comparison between robot-assisted lobectomy and hypofractionated proton beam therapy in stage I non-small cell lung cancer [active]
    Institutional principal investigator: Kwan Ho Cho
  • Phase II hypofractionated proton beam therapy for recurrent gliomas of the brain after previous radiotherapy [closed]
    Institutional principal investigator: Kwan Ho Cho
  • Phase I dose escalation study using proton beam therapy for recurrent head and neck carcinoma after previous radiotherapy [closed]
    Institutional principal investigator: Kwan Ho Cho
  • Prospective study of proton beam craniospinal radiotherapy in children with newly-diagnosed medulloblastoma (Assessment of acute and long term sequelae and quality of life) [active]
    Institutional principal investigator: Joo-Young Kim
  • Para-aortic LN irradiation using proton beam radiotherapy for isolated para-aortic recurrence of gynecologic cancer [active]
    Institutional principal investigator: Joo-Young Kim
  • A prospective observational study for investigation of the role of postoperative proton beam therapy in Korean pediatric patients with CNS ependymoma [active]
    Institutional principal investigator: Joo-Young Kim
  • Evaluation of the treatment-related toxicities of proton beam craniospinal radiotherapy (CSRT) in the patients with brain tumors [active]
    Institutional principal investigator: Joo-Young Kim
  • A phase II study of proton beam radiotherapy for recurrent pelvic disease in patients with gynecologic cancer [closed]
    Institutional principal investigator: Joo-Young Kim
  • Proton therapy concurrently combined with oxaliplatin and capecitabine for liver or lung metastases in patients with cororectal cancer: phase II study [closed]
    Institutional principal investigator: Dae Yong Kim
  • Phase II study of proton beam accelerated partial breast irradiation (PB-APBI) after lumpectomy in patients with early breast cancer [active]
    Institutional principal investigator: Kyung Hwan Shin
facebook twitter email